Pathophysiology of Cardiac Performance

Cardiac performance depends on heart rate, heart rhythm, myocardial contraction, and blood flow. The heart's rate and rhythm are regulated by a specialized conducting system that coordinates synchronized contractions through cardiomyocytes via voltage-sensitive channels. These factors work together to ensure efficient pumping and oxygen delivery throughout the body.

Stroke volume is determined by preload, afterload, and myocardial contractility. Preload represents the initial stretching of cardiomyocytes before contraction, related to left ventricular filling pressure. Afterload is the resistance encountered during blood pumping, represented by aortic impedance and systemic vascular resistance. The Frank-Starling law states that stroke volume increases proportionally to end-diastolic volume.

Abnormalities in the specialized conducting system can result in arrhythmias. These include myocardial damage, conducting system defects, or increased sympathetic activity. Such disruptions prevent proper coordination of synchronized contractions through cardiomyocytes, leading to irregular heart rhythms that compromise cardiac output and oxygen delivery.

Myocardial ischemia impairs contractility, increasing cardiac workload and oxygen consumption. Conditions such as atherosclerosis and hormonal or metabolic responses to stress may reduce coronary flow, leading to ischemia or angina. Myocardial oxygen consumption relies on coronary blood flow, which is regulated by various physiological factors including arterial pressure, vascular resistance, and vessel diameter.

The autonomic nervous system comprises sympathetic and parasympathetic branches that regulate heart rate. Sympathetic activation increases heart rate through increased contractility and conduction velocity. Parasympathetic activation reduces heart rate. These opposing effects allow the heart to adjust its output according to the body's metabolic demands and stress responses.

Coronary blood flow is regulated by physical factors including arterial pressure, vascular resistance, and vessel diameter. Metabolite-driven vascular control involves adenosine, nitric oxide, and endothelin, which modulate coronary vasodilation and constriction. Neural and humoral control mechanisms involving neurotransmitters and hormones further influence coronary blood flow to maintain heart function.

Cardiovascular drugs can affect cardiac function via alteration of electrophysiology, contraction, oxygen consumption, and coronary blood flow or autonomic control. Heart failure drugs like inhibitors of renin angiotensin system help restore cardiac performance by reducing afterload and improving contractility. These medications address underlying pathophysiological mechanisms to improve heart function and patient outcomes.